Medroxyprogesterone Acetate Injection, Suspension
Product Images NDC 55150-329

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Medroxyprogesterone Acetate (NDC 55150-329). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 Risk Estimates For Breast Cancer In Dmpa Users (Medroxyprogesterone Fig1)

A forest plot displaying odds ratios with 95% confidence intervals on a logarithmic scale from various studies and data sets assessing risk related to Medroxyprogesterone Acetate (DMPA) use. The plot includes data points from studies spanning 1987 to 2012, showing odds ratios ranging approximately from 0.9 to 2.6, with individual confidence intervals represented by horizontal lines.*

FDA Label Image

Chart (Medroxyprogesterone Fig2)

An illustration diagram showing a vertical arrow labeled 'Fewer Pregnancies' at the top and 'More Pregnancies' at the bottom, with pregnancy rates per 100 women in one year along the left side. Various birth control methods are listed to the right in boxes aligned vertically according to their effectiveness, ranging from 'Implants, Injections, Intrauterine devices, Sterilization' (top) to 'No birth control' (bottom).*

FDA Label Image

Package Label-principal Display Panel-150 mg Per mL (Container Label)

Label for MEDROXYPROGESTERONE ACETATE Injection, Suspension, USP 150 mg per mL. The label states it is for intramuscular use only and comes as a 1 mL single-dose vial. It includes storage instructions, dosage guidance, manufacturer details (AuroMedics Pharma LLC, India), and a barcode.*

FDA Label Image

Package Label-principal Display Panel-150 mg Per mL (Container-Carton (1 Vial))

Carton packaging label for Medroxyprogesterone Acetate Injection, Suspension, USP 150 mg/mL. The product is for intramuscular use only, supplied in a 1 mL single-dose vial. The label shows the product is distributed by AuroMedics Pharma LLC and is made in India. Storage instructions and additional vial information are included.*

FDA Label Image

Package Label-principal Display Panel-150 mg Per mL (Container-Carton (25 Vials))

Packaging label for Medroxyprogesterone Acetate Injectable Suspension USP 150 mg per mL, for intramuscular use only. The carton states 25 single-dose vials of 1 mL each. It includes storage instructions, manufacturer information (Auromedics Pharma LLC), and a barcode. The label emphasizes the suspension form and the prescription-only status.*

FDA Label Image

Chemical Structure (Medroxyprogesterone Str)

Chemical structure diagram of medroxyprogesterone acetate, the active ingredient in the product MEDROXYPROGESTERONE ACETATE 150 mg/mL injection suspension by Eugia US LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.